Reduced Tubulin Acetylation in Membrane Lipid Rafts Linked to Depression

Summary: Individuals with depression show higher levels of unmodified tubulin in membrane lipid rafts than non-depressed individuals, which may impair Gαs signaling and offer new avenues for diagnostics and treatment.

Source: University of Illinois

Key Findings

Researchers at the University of Illinois at Chicago report that postmortem prefrontal cortex tissue from people diagnosed with depression contains a higher proportion of unacetylated (less modified) α-tubulin associated with plasma membrane lipid rafts compared with tissue from non-depressed controls. This altered tubulin acetylation coincides with previously observed increases in Gαs protein localization to lipid rafts in depressed subjects — a localization that reduces Gαs coupling to adenylyl cyclase and lowers cAMP signaling.

Background

Tubulin is a core component of the cytoskeleton and plays a structural role in cells. Beyond structural support, tubulin interacts with signaling proteins, including Gαs, a G-protein subunit that transmits signals from neurotransmitters such as serotonin to adenylyl cyclase to produce cyclic AMP (cAMP). Previous studies showed that in depression Gαs becomes concentrated in lipid raft domains of the membrane where it couples less effectively with adenylyl cyclase. Antidepressant treatments and inhibition of histone deacetylase 6 (HDAC6) can shift Gαs out of lipid rafts and restore signaling, suggesting the tubulin–Gαs interaction and tubulin post-translational modification could be central to the mechanism.

What the Study Did

Mark Rasenick and colleagues analyzed postmortem brain samples from depressed and non-depressed individuals, including a subgroup of depressed subjects who died by suicide. They measured levels of acetylated α-tubulin in whole tissue homogenates, isolated plasma-membrane fractions, and lipid-raft membrane fractions. The team also assessed the expression of HDAC6 and the α-tubulin acetyltransferase responsible for adding acetyl groups to tubulin.

Results

The study found no significant differences in tubulin acetylation in whole tissue homogenates across groups. However, membrane-associated tubulin — and in particular tubulin within lipid rafts — showed a marked decrease in acetylation in both depressed-suicide and depressed non-suicide groups compared to controls. Expression levels of HDAC6 and the tubulin acetyltransferase were not significantly altered, indicating the observed changes reflect differences in tubulin acetylation state localized at the membrane rather than changes in total enzyme abundance.

Interpretation

The data support a model in which lower acetylation of membrane-associated tubulin promotes sequestration of Gαs within lipid raft domains. When Gαs is anchored in lipid rafts, its coupling to adenylyl cyclase is reduced, decreasing cAMP production — a signaling deficit linked to depression. Antidepressant treatments and HDAC6 inhibition both increase tubulin acetylation and allow Gαs to relocate out of lipid rafts, restoring more effective signaling. These findings identify membrane-localized tubulin acetylation as an influential factor in the molecular pathology of depression.

Clinical and Diagnostic Implications

PAX Neuroscience Inc., a company founded by Rasenick, is exploring whether Gαs localization and tubulin-related changes could serve as blood-based diagnostic biomarkers to identify individuals with depression and to rapidly assess antidepressant response. If membrane tubulin acetylation or Gαs distribution can be measured in accessible cells, it may lead to faster, biologically based diagnostics and new therapeutic strategies aimed at normalizing tubulin acetylation and Gαs signaling.

Quote from the Research Team

“This work is important because many people with depression do not seek treatment, often due to stigma,” said Mark Rasenick. “Identifying a biological basis for depression may help reframe it as a treatable medical condition and reduce stigma, encouraging more individuals to pursue care.”

Authors and Funding

Co-authors on the study include Harinder Singh, Justyna Chmura, Runa Bhaumik and Ghanshyam Pandey, together with Mark M. Rasenick. Funding was provided by grants from the U.S. Department of Veterans Affairs, the National Institutes of Health, and the American Heart Association.

Original Research

The study is published in the Journal of Neuroscience under the title: “Membrane-associated α-tubulin is less acetylated in postmortem prefrontal cortex from depressed subjects relative to controls: cytoskeletal dynamics, HDAC6 and depression.” DOI: 10.1523/JNEUROSCI.3033-19.2020. The article presents postmortem evidence linking decreased membrane tubulin acetylation to increased Gαs sequestration in lipid rafts and attenuated cAMP signaling in depression.

Abstract Summary

Post-translational modifications of cytoskeletal proteins, including tubulin acetylation, can influence microtubule dynamics and signaling interactions. In human postmortem prefrontal cortex, depressed subjects exhibited reduced acetylation of membrane-associated α-tubulin and increased Gαs localization to lipid rafts, without changes in expression of acetylation-related enzymes. These findings suggest membrane tubulin modification contributes to impaired Gαs–adenylyl cyclase coupling in depression, highlighting a potential diagnostic and therapeutic target.

Media Contact: Jackie Carey – University of Illinois

Feel free to share this news about advances in depression research.